These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23750482)

  • 1. Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations.
    Kaneko MK; Tsujimoto Y; Hozumi Y; Goto K; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):224-8. PubMed ID: 23750482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation.
    Kato Y; Natsume A; Kaneko MK
    Biochem Biophys Res Commun; 2013 Mar; 432(4):564-7. PubMed ID: 23485467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.
    Kato Kaneko M; Ogasawara S; Kato Y
    Tohoku J Exp Med; 2013 Jun; 230(2):103-9. PubMed ID: 23782684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.
    Kaneko MK; Tian W; Takano S; Suzuki H; Sawa Y; Hozumi Y; Goto K; Yamazaki K; Kitanaka C; Kato Y
    Biochem Biophys Res Commun; 2011 Mar; 406(4):608-13. PubMed ID: 21352804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.
    Kato Y
    Brain Tumor Pathol; 2015 Jan; 32(1):3-11. PubMed ID: 25324168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas.
    Fujii Y; Ogasawara S; Oki H; Liu X; Kaneko MK; Takano S; Kato Y
    Biochem Biophys Res Commun; 2015 Oct; 466(4):733-9. PubMed ID: 26381180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.
    Kaneko MK; Morita S; Tsujimoto Y; Yanagiya R; Nasu K; Sasaki H; Hozumi Y; Goto K; Natsume A; Watanabe M; Kumabe T; Takano S; Kato Y
    Biochem Biophys Res Commun; 2013 Mar; 432(1):40-5. PubMed ID: 23376717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations.
    Ogasawara S; Kaneko MK; Tsujimoto Y; Liu X; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):377-81. PubMed ID: 24328739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.
    Liu X; Ogasawara S; Kaneko MK; Oki H; Hozumi Y; Goto K; Takagi M; Kato Y
    Biochem Biophys Res Commun; 2015 Apr; 459(4):636-42. PubMed ID: 25753205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation.
    Kato Y; Jin G; Kuan CT; McLendon RE; Yan H; Bigner DD
    Biochem Biophys Res Commun; 2009 Dec; 390(3):547-51. PubMed ID: 19818334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.
    Agarwal S; Sharma MC; Jha P; Pathak P; Suri V; Sarkar C; Chosdol K; Suri A; Kale SS; Mahapatra AK; Jha P
    Neuro Oncol; 2013 Jun; 15(6):718-26. PubMed ID: 23486690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma.
    Pusch S; Schweizer L; Beck AC; Lehmler JM; Weissert S; Balss J; Miller AK; von Deimling A
    Acta Neuropathol Commun; 2014 Feb; 2():19. PubMed ID: 24529257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
    Bleeker FE; Lamba S; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Frattini M; Molinari F; Knowles M; Cerrato A; Rodolfo M; Scarpa A; Felicioni L; Buttitta F; Malatesta S; Marchetti A; Bardelli A
    Hum Mutat; 2009 Jan; 30(1):7-11. PubMed ID: 19117336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation.
    Kato Y; Kaneko MK
    Biochem Biophys Res Commun; 2013 Apr; 433(4):374-8. PubMed ID: 23524262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors.
    Takano S; Kato Y; Yamamoto T; Kaneko MK; Ishikawa E; Tsujimoto Y; Matsuda M; Nakai K; Yanagiya R; Morita S; Tsuboi K; Matsumura A
    J Neurooncol; 2012 Jul; 108(3):361-73. PubMed ID: 22396072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Influence of Hotspot Mutations in Protein-Protein Interaction of IDH1 Homodimer Protein: A Computational Approach.
    Thirumal Kumar D; Sneha P; Uppin J; Usha S; George Priya Doss C
    Adv Protein Chem Struct Biol; 2018; 111():243-261. PubMed ID: 29459034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody specific for IDH1 R132H mutation.
    Capper D; Zentgraf H; Balss J; Hartmann C; von Deimling A
    Acta Neuropathol; 2009 Nov; 118(5):599-601. PubMed ID: 19798509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry using monoclonal antibody MsMab-2 is useful to detect IDH1 R132L in intrahepatic cholangiocarcinoma.
    Hayashi A; Misumi K; Shibahara J; Kokudo N; Kato Y; Fukayama M
    Pathol Int; 2016 Oct; 66(10):578-582. PubMed ID: 27595804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death.
    Mohrenz IV; Antonietti P; Pusch S; Capper D; Balss J; Voigt S; Weissert S; Mukrowsky A; Frank J; Senft C; Seifert V; von Deimling A; Kögel D
    Apoptosis; 2013 Nov; 18(11):1416-1425. PubMed ID: 23801081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR- and restriction endonuclease-based detection of IDH1 mutations.
    Meyer J; Pusch S; Balss J; Capper D; Mueller W; Christians A; Hartmann C; von Deimling A
    Brain Pathol; 2010 Mar; 20(2):298-300. PubMed ID: 19744125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.